Internship

Spring 2025 Co-op: AAV Biology

Posted on 9/6/2024

Prime Medicine

Prime Medicine

201-500 employees

Gene editing technology for genetic diseases

Biotechnology
Healthcare

Cambridge, MA, USA

Candidates must be from the local Boston/Cambridge area.

Category
Genomics
Biology Lab & Research
Biology & Biotech
Requirements
  • Direct experience working in a laboratory setting and demonstrated ability to perform routine laboratory procedures.
  • Experience conducting experiments, collecting and analyzing experimental data, and presenting results to the larger team.
  • Rigorous and conscientious, exhibiting care and thoroughness in experiment execution and data interpretation.
  • Motivation and passion for driving effective gene editing therapeutic to patients.
  • B.S. or M.S. candidate in Cell & Molecular Biology or related major.
  • Effective communication skills, with the ability to describe research clearly and concisely to a cross-disciplinary audience
  • Goal-driven, with strong organizational skills, including record keeping, documentation, and reporting of research.
  • Highly adaptable and comfortable in an environment with dynamic priority demands.
  • Ability to work independently and within a team
Responsibilities
  • Assist the team with AAV production and quality characterization utilizing basic aseptic cell culture technique, ddPCR, SDS PAGE, Silver Staining, denaturing gel electrophoresis, and other relevant techniques and assays.
  • Contribute to the team’s efforts to characterize and optimize Prime’s AAV delivery platform with a variety of molecular and cell biology activities to include DNA and RNA purification, common cloning methods (eg. Gibson assembly), NGS sample preparation, qPCR, etc.
  • Assist with experimental design and conduct experiments to characterize newly designed vectors and impact on efficacy and safety.
  • Contribute to the scientific discussions and output of the team
  • Collect and analyze experimental data, compile experimental summaries in an Electronic Lab Notebook (ELN), and present results to the larger team
  • Adhere to all laboratory safety requirements and procedures

Prime Medicine focuses on gene editing, specifically using a technology called Prime Editing to make precise changes to DNA. This technology can identify and fix faulty DNA segments, which helps restore normal genetic function. The company aims to cure, halt, or prevent genetic diseases, providing long-term benefits to patients. Unlike many competitors, Prime Medicine collaborates with research institutions and pharmaceutical companies to advance its technology and bring it to market, generating revenue through licensing and partnerships. The leadership team has significant experience in developing innovative medicines, highlighting the company's commitment to enhancing its capabilities and operations.

Company Stage

IPO

Total Funding

$306.4M

Headquarters

Cambridge, Massachusetts

Founded

2019

Growth & Insights
Headcount

6 month growth

2%

1 year growth

7%

2 year growth

45%
Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic partnerships, like with Bristol Myers Squibb, offer significant financial and developmental benefits.
  • Increased investment interest, such as the $15M from CF Foundation, boosts research capabilities.
  • The $161M PIPE offering provides substantial capital for growth and innovation.

What critics are saying

  • Patent litigation risks could lead to costly legal battles and financial liabilities.
  • Dependency on strategic partnerships may pose risks if collaborations don't meet expectations.
  • Reliance on external funding through PIPE offerings could be risky if market conditions change.

What makes Prime Medicine unique

  • Prime Medicine uses Prime Editing for precise DNA modifications, setting it apart in biotech.
  • The company targets genetic disorders, a vast market with millions of potential beneficiaries.
  • Prime Medicine's leadership includes industry veterans, enhancing its credibility and operational expertise.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE